Manufacturer record
Saitech Medicare Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
7 batches manufactured by Saitech Medicare Pvt. Ltd (Himachal Pradesh) were declared Not of Standard Quality between January 2019 and March 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: SML-2643, Dextromethorphan, Phenylephrine and Chlorpheniramine Syrup (exp Nov 2027). RDTL, Chandigarh (CDSCO lab) found it not of standard quality: The sample does not conform to claim as per Patent and Proprietary in respect to the Assay of Phenylephrine Hydrochloride. Listed in the March 2026 alert.
Records by type
7 records linked to Saitech Medicare Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Dextromethorphan, Phenylephrine and Chlorpheniramine Syrup | Batch SML-2643Mfg Dec 2025 · Exp Nov 2027 | The sample does not conform to claim as per Patent and Proprietary in respect to the Assay of Phenylephrine HydrochlorideAssay | RDTL, ChandigarhCDSCO lab | Mar 2026 |
| Ambroxol, Levosalbutamol Guaiphenesin Syrup | Batch SML-2465Mfg Mar 2024 · Exp Feb 2026 | AssayAssay | DTL/BaddiState lab | Sep 2025 |
| Cefpodoxime Proxetil Dispersible Tablets (TROYPOD 200 TABLETS) | Batch CT-0778AMfg Dec 2023 · Exp Nov 2025 | DissolutionDissolution | RDTL ChandigarhCDSCO lab | Mar 2024 |
| Metformin Hydrochloride Prolonged-release and Glimepiride Tablets IP (Glimipulse M1 Tablets) | Batch SGT- 0624AMfg Dec 2022 · Exp Nov 2024 | Assay of GlimepirideAssay | RDTL ChandigarhCDSCO lab | Jul 2023 |
| Amoxycillin and Potassium Clavulanate Tablets IP | Batch PT-0681AMfg Jan 2021 · Exp Dec 2022 | Dissolution of Amoxycillin and Clavulanic AcidDissolution | RDTL GuwahatiState lab | May 2022 |
| Amoxycillin And Potassium Clavulanate Tablets I.P. (Clavage-1000) | Batch SBPT-4321Mfg Feb 2018 · Exp Jul 2019 | Test for DissolutionDissolution | RDTL GuwahatiState lab | Jun 2019 |
| Amoxycillin & Potassium Clavulanete Tablets I.P. (Amofive CL 625) | Batch SBPT-4686Mfg May 2018 · Exp Oct 2019 | Assay of Amoxycillin & DissolutionAssay | RDTL GuwahatiState lab | Jan 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.